APA (7th ed.) Citation

Elmarasi, M., Elkonaissi, I., Elsabagh, A. A., Elsayed, E., Elsayed, A., Elsayed, B., . . . Yassin, M. (2024). CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up. International Immunopharmacology, 135, N.PAG. https://doi.org/10.1016/j.intimp.2024.112312

Chicago Style (17th ed.) Citation

Elmarasi, Mohamed, Islam Elkonaissi, Ahmed Adel Elsabagh, Engy Elsayed, Abdelrahman Elsayed, Basant Elsayed, Ibrahim Elmakaty, and Mohamed Yassin. "CAR-T Cell Therapy: Efficacy in Management of Cancers, Adverse Effects, Dose-limiting Toxicities and Long-term Follow Up." International Immunopharmacology 135 (2024): N.PAG. https://doi.org/10.1016/j.intimp.2024.112312.

MLA (9th ed.) Citation

Elmarasi, Mohamed, et al. "CAR-T Cell Therapy: Efficacy in Management of Cancers, Adverse Effects, Dose-limiting Toxicities and Long-term Follow Up." International Immunopharmacology, vol. 135, 2024, p. N.PAG, https://doi.org/10.1016/j.intimp.2024.112312.